CyGenica

Pushing the boundaries of cancer therapy to bring better outcome for millions of cancer patients worldwide

What is the Challenge?

Millions of cancer patients need to be hospitalized repeatedly during their treatment to get high doses of chemotherapy. Aside from destroying cancer cells, the chemotherapy also causes damage to normal cells, causing severe side effects that sometimes are more debilitating than cancer itself, making the patient suffer. The challenge of delivering drugs for cancer and genetic therapies, across cell membranes without damaging the cells and triggering an adverse immune response, is a complex hurdle in the pharmaceutical industry.

What is the Solution?

Subscribe for the latest updates

Subscribe to EQT Foundation's press releases and updates.

@ Stiftelsen EQT Foundation 2021 . Registrated office in Stockholm, Sweden. Registration number: 802481-2821